Please login to the form below

Not currently logged in
Email:
Password:

prescription drugs

This page shows the latest prescription drugs news and features for those working in and with pharma, biotech and healthcare.

PhRMA opposed to Senate drug price control plans

PhRMA opposed to Senate drug price control plans

prescription drug benefit that could save $85bn over the next decade, according to its backers. ... The cost of many prescription drugs is too high,” said Grassley and Wyden in a joint statement.

Latest news

More from news
Approximately 2 fully matching, plus 171 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    11. Buvidal – an advance in opioid dependence treatment. Opioid addiction has surged in the US since the 1990s, when prescription drugs such as OxyContin and Vicodin became a common remedy for ... Now there is a growing need for treatments which can

  • Behaviour change – a missing ingredient? Behaviour change – a missing ingredient?

    There is plenty of evidence to show that some things are bad for us: smoking, too much sugar, alcohol and drugs, for example.So why is it that some of us ... For example, providing prescription drugs in different colours to encourage adherence, or

  • US health reforms US health reforms

    In a very real way, the cost of drugs in US - the only developed nation without some form of cost control - can affect the global marketplace. ... Several studies have shown that the United States spends considerably more per capita on prescription drugs

  • Re-awakening the emotion in healthcare communications Re-awakening the emotion in healthcare communications

    phrases. For healthcare companies, it was the same. However, it started to change when the ABPI established the Prescription Medicines Code of Practice Authority (PMCPA) in 1993 to operate the Code ... At the time, they knew the campaign would test the

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    The accompanying figure summarises the measures that target spending on prescription drugs. ... Governments have typically begun by exploring opportunities to negotiate lower prices for orphan drugs.

More from intelligence
Approximately 0 fully matching, plus 27 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics